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Seasonal influenza is an important public health issue, with conservative 
estimates of 25 excess deaths per 100,000 people each season, for a 
potentially preventable illness.1 Controlling influenza transmission in healthcare 
settings is important given greater environmental exposure due to high 
concentrations of infected patients (some not identified as  influenza cases) and 
possible transmission between health care workers (HCWs) and patients. 
Healthcare facilities host some of the most vulnerable patient groups at risk of 
severe or complicated infection, particularly the elderly or those with chronic 
underlying health problems.2 Nosocomial outbreaks are described in a number 
of different healthcare settings3 and nosocomial attack rates are estimated at 
around 1 in 200 hospital admissions.4 Attack rates may be higher and the 
consequences more severe in high risk settings or within vulnerable 
populations such as residents of elderly care homes. Indeed those over 65 
years account for 90% of influenza-related deaths.5  
 
Healthcare organisations have a duty of care to protect both HCWs and 
patients. Annual immunisation of HCWs is widely recommended by public 
health  as a primary control measure with the dual aims of providing both direct 
protection for HCWs and indirect protection for their patients.. However, for 
decades it has been recognised that evidence for the effectiveness of 
vaccination in providing direct protection of HCWs is limited.6 Logically it may 
be expected, given the close contact nature of health care provision, that HCWs 
are at increased risk of exposure to influenza. Despite this, it has not been 
established that they are at any greater risk of influenza illness through work. 
One study suggested that influenza illness in HCWs is more strongly associated 
with household rather than occupational exposures.7 While the rate of both 
symptomatic and asymptomatic influenza in HCWs may be elevated compared 
with non-health workers, a recent systematic review could not identify from the 
limited evidence why this occurs and whether it is a direct consequence of 
health care itself.8 Recent evidence suggests that in the healthy adult 
population, vaccination has a very modest effect with an average overall 
reduction in absence from work of just 0.04 days,9 but these data do not 
contradict the evidence that vaccination in HCWs protects vulnerable patients. 
 
There is some evidence, albeit limited, that influenza vaccination of HCWs 
provides indirect protection to the highly vulnerable residents of elderly care 
homes.  A number of systematic reviews have assessed this evidence,10-13 the 
highest quality evidence coming from four cluster randomised controlled trials 
(RCTs).14-17 While there is consistency in the direction of effect across several 
outcome measures, a number of other factors including non-blinding of staff 
and differences in vaccination coverage or health status between  cases and 
controls limits causal inference. There are also methodological concerns about 
the conclusion of these four RCTs. For example, in the study by Potter et al. 
the divergence in morbidity and mortality preceded the influenza outbreak and 
was possibly unrelated to influenza17  .  In the studies by Carman and Hayward 
data on the temporal relationship between influenza and mortality and 
confounding effects of disability and patient vaccination were not fully controlled 
for.14,15 In another study, staff awareness in vaccinated homes may have 
increased use of general preventive measures effective also against other 
respiratory viruses such as respiratory syncytial virus (RSV).16 The reduced 
morbidity and mortality in the Lemaitre study occurred before the influenza 
outbreak, shortly after the RSV outbreak peak and probably related to it.18 
Moreover, it remains unclear whether the findings from elderly care home 
settings with relatively stable resident and staff populations can be extrapolated  
to acute care settings characterised by short lengths of stay and high patient 
throughput. 
 
In the 2013/2014 and 2014/15 seasons, 55% of all frontline HCWs in England  
reportedly received the influenza vaccine19..19 Although the existing evidence 
is not strong and heavily weighted towards the benefits to residents of long-
term care facilities, it is likely that vaccination of HCWs offers some indirect 
protection to high-risk patient groups. An increased focus should therefore be 
placed on vaccination of carers and HCWs in these settings. 
 
Annual vaccination of individuals aged 65 years and over is also recommended 
in many national policies as a primary control measure. Initially, vaccine uptake 
amongst the elderly was low, but has substantially improved since the 1990s 
with achievement of the 75% target in England and the Netherlands by the 
2008/9 season.20 Concerns have been reported that the elderly are less able to 
mount an immune response following vaccination21 with a paucity of studies to 
indicate effectiveness in this group.22  While one RCT reported an efficacy of 
58%23, the most recent  Cochrane review24 of 75 studies was unable to draw a 
conclusion about the effectiveness of vaccination (measured by onset of 
influenza like illness) based on pooled data  from  poor quality  non-RCT 
studies. Vaccine effectiveness differs every season as it depends on the 
matching of vaccine and circulating strains.. Debate about the direct mortality 
reduction in the elderly25 centres on potential different exposure risk in 
vaccinated and unvaccinated persons.  Hence variation of the estimated 
effectiveness between places and seasons could obscure real protective effect 
on mortality, as evidenced by opposing interpretations of the Cochrane Review 
dataset.24, 26 Despite the limited evidence, the influenza-associated 
hospitalizations and mortality  in the elderly, may still justify vaccination , even 
if only moderately effective, to reduce this large burden of disease.27 
 
Vaccination  will not completely prevent  transmission on its own, particularly in 
seasons with significant antigenic drift and mismatch between vaccine and 
circulating strains such as in the recent 2014-15 season.28  While influenza 
immunisation is generally safe, immunity elicited by vaccination is shorter lived 
when compared to naturally acquired immunity, which may provide long-lasting 
protection against subsequent infection. Modelling has suggested that repeated 
vaccination at a young age may increase the risk of influenza in older age, by 
a factor ranging between 1.2 to 2.4 29 but other research data contradicts this.30, 
31 
 
Given these limitations and the difficulties in achieving high annual vaccine 
uptake rates, the future may lie with the development of a universal vaccine 
that would not require seasonal administration.32 Vaccination should only be 
seen as one element of a broad package of control measures including hand 
hygiene and use of appropriate barrier control measures.2,33 While evidence 
exists for these, it remains poorly quantified.34,35 Even when such control 
systems are in place, they may not always be adhered to. Compliance with 
hand hygiene for example has been reported to be as low as 40% in some 
health care settings.36 Hygiene measures are often considered in isolation from 
vaccination and may attract more attention during outbreaks rather than primary 
prevention of infection. Within healthcare environments, viral shedding can be 
prolonged, possibly beginning at least one day before clinical illness with the 
duration depending on the age and immune status of the affected person.37 
Hand hygiene and administrative barrier control  measures are  therefore 
important in disrupting virus transmission. 38 
 
Control of transmission as it currently stands remains suboptimal and 
nosocomial influenza outbreaks continue to occur.39 Further research is needed 
to fully understand the transmission of nosocomial influenza and the 
effectiveness of interventions to control spread. Epidemiological understanding 
of transmission of influenza in the healthcare setting remains incomplete.37 This 
is a complicated area of research due to multiple confounding factors. These 
include the source and route of viral transmission, clinical identification of cases 
(including serological classification which is challenging to interpret post 
vaccination), the patient’s health status and effectiveness and implementation 
of any hygiene controls. Within studies ideally only specific endpoints for 
virologically confirmed influenza should be used, if possible reverse 
transcriptase polymerase chain reaction (RT-PCR), but often this is neither 
available nor feasible. Seasonal incidence of influenza is unpredictable and 
highly variable and thus assessment of interventions occurring during mild 
seasons with fewer than expected cases may be underpowered to assess 
specific outcomes. 
 
In the absence of high quality evidence37, authorities advocate application of 
the ‘precautionary principle’ approach. 40   In practice this means applying a 
broad package of control measures in settings to most effect and further 
evaluating interventions as they are used. Efforts should be re-focused in order 
to have a greater overall impact on influenza transmission. Whilst emergent, 
but still quite limited, evidence confirms transmission between HCW and 
patients,37, 41 other groups such as visitors and non-clinical staff are also likely 
to play a part, particularly in semi-closed settings such as elderly care homes. 
Such groups could be more closely engaged in preventative strategy and 
implementation. Higher risk ‘health care’ settings such as elderly care homes 
should also be clearly defined and targeted more closely with the full hierarchy 
of influenza control measures. This should be supported by consistent 
messages from occupational health, public health and infection control 
professionals with wider public education. 
  
Applying a traditional risk management approach such as the ‘Hierarchy of 
Control’42 may help to structure control measures in mitigating the risk of 
nosocomial infection in patients. As with any identified hazard, risk evaluation 
should lead to control measures which should start from the top of the 
hierarchy. Hence if the risk cannot be eliminated, the duty to control it to an 
acceptable level remains. Risk reduction may be achieved by limiting admission 
of patients to long-stay elderly care homes during outbreaks. This is particularly 
important when there is a laboratory confirmed RT-PCR influenza outbreak. 
Minimising visitors, especially children or any child/adult with symptoms during 
the seasonal flu period, immunising residents/patients, HCWs/care-staff and 
visitors and excluding any symptomatic staff who may still present for work are 
all important.43 Hazard substitution is not possible. Engineering controls may 
include isolation where possible through single rooms, or distancing. Other 
measures include cough and sneeze etiquette, or personal protective 
equipment such as face masks for residents/patients and possibly carers 
(although limited evidence of effectiveness exists for this),44 and especially 
hand washing.  
 
Additional measures can be considered in acute care settings: isolating patients 
with suspected or confirmed influenza, limiting aerosol-generating procedures 
only to adequately ventilated single rooms before influenza can be excluded, 
provision of face masks for patients with acute respiratory infections until 
symptoms abate,44 checking and maintaining air-conditioning units and settings 
to avoid airflow imbalance, and providing HCWs with appropriate respirators, 
gloves, and gowns while performing aerosol-generating procedures. Finally, 
when an outbreak is detected in a nosocomial setting, currently NICE45 and 
PHE46 recommend consideration of neuraminidase inhibitors (NAIs) for post-
exposure prophylaxis, alongside the physical and administrative infection 
control measures outlined above. The evidence for this is debated, with the 
latest Cochrane review concluding that using NAIs for prophylaxis “reduces the 
risk of developing symptomatic influenza”, although the authors also state that 
“the balance between benefits and harms should be considered.” 47  
Administrative controls may include training and education of staff and visitors, 
and redeployment of unvaccinated staff where appropriate.  
 
The current emphasis on HCW immunisation fosters the belief in health care 
providers that the duty of care to vulnerable patients and HCWs is discharged 
by merely implementing an employee influenza vaccination programme. 
However current controls are obviously suboptimal as outbreaks continue to 
occur. We need to reassess engagement and compliance with a broad set of 
control measures. Re-structuring and targeting efforts towards the higher risk 
settings, particularly elderly care homes, may have a greater overall impact. 
Risk assessments could determine where weaknesses in the hierarchy of 
control occur.  
 
Influenza should be recognised and labelled as a ‘healthcare-associated 
infection’ (HCAI), given its associated morbidity/mortality and should have 
similar focus and attention as the more commonly recognised HCAIs such as 
MRSA.48 
 
Whilst vaccination of HCWs is necessary, on its own it may not be sufficient to 
prevent nosocomial influenza infection and a multidimensional approach is 
clearly requiredThis is a much greater challenge than for occupational health 
alone and requires collaboration with public health, patient safety, infection 
control, quality and clinical governance functions. Commissioners of healthcare 
need a new multidisciplinary strategy (encompassing the full hierarchy of 
primary, secondary and tertiary controls) to reduce nosocomial influenza 
infections. 
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